WHIPPANY, N.J., April 22 /PRNewswire/ -- Halo Pharmaceutical, this week announced that it has completed $14.6 million in financing from The Provident Bank to expand its operations. Headquartered in Whippany, Halo is a privately held full-service, specialty pharmaceutical company.

WHIPPANY, N.J., April 20 /PRNewswire/ -- As part of a Research and Development partnership between Halo Pharmaceutical and DeMelleBioPharma, LLC, Dr. George Bobotas joins Halo Pharmaceutical as Chief Scientific Officer.

Clive V.

WHIPPANY, N.J., Jan. 26 /PRNewswire/ -- Adding to its strong executive team, Halo Pharmaceutical today announced the addition of Allen M. Rosenston, a thirty-five year pharmaceutical industry veteran, as Halo's new Vice President of Business Development.